Diagnostik und Therapie des Typ 1 Diabetes mellitus (Update 2023)

M Lechleitner; S Kaser; F Hoppichler; M Roden; Raimund Weitgasser; B Ludvik; P Fasching; Y Winhofer; A Kautzky-Willer; G Schernthaner; R Prager; TC Wascher; M Clodi

doi:10.1007/s00508-023-02182-8

Diagnostik und Therapie des Typ 1 Diabetes mellitus (Update 2023)

Translated title of the contribution: Diagnosis and insulin therapy of type 1 diabetes mellitus (Update 2023): Diagnosis and insulin therapy of type 1 diabetes mellitus (Update 2023)

M Lechleitner, S Kaser, F Hoppichler, M Roden, Raimund Weitgasser (Co-author), B Ludvik, P Fasching, Y Winhofer, A Kautzky-Willer, G Schernthaner, R Prager, TC Wascher, M Clodi

Department of Internal Medicine I- Division of Gastroenterology, Hepatology, Nephrology, Metabolism and Diabetologylog
A.ö. Krankenhaus der Barmherzigen Brüder Salzburg

Research output: Contribution to journal › Original Article › peer-review

1 Citation (Web of Science)

Translated title of the contribution	Diagnosis and insulin therapy of type 1 diabetes mellitus (Update 2023): Diagnosis and insulin therapy of type 1 diabetes mellitus (Update 2023)
Original language	German
Pages (from-to)	98-105
Journal	WIENER KLINISCHE WOCHENSCHRIFT
Volume	135
Issue number	SUPPL 1
DOIs	https://doi.org/10.1007/s00508-023-02182-8
Publication status	Published - 2023

Keywords

BASAL-BOLUS REGIMEN
GLARGINE 300 U/ML
SEVERE HYPOGLYCEMIA
AUTOIMMUNE-DISEASE
CELIAC-DISEASE
ANALOGS
RISK
PRONE
PREVALENCE
ANTIBODIES

Access to Document

10.1007/s00508-023-02182-8

Cite this

@article{0c072fc9ca6c42828776f09c40306209,

title = "Diagnostik und Therapie des Typ 1 Diabetes mellitus (Update 2023)",

keywords = "BASAL-BOLUS REGIMEN, GLARGINE 300 U/ML, SEVERE HYPOGLYCEMIA, AUTOIMMUNE-DISEASE, CELIAC-DISEASE, ANALOGS, RISK, PRONE, PREVALENCE, ANTIBODIES, Humans, Insulin/therapeutic use, Diabetes Mellitus, Type 1/diagnosis, Hypoglycemic Agents/therapeutic use, Diabetes Mellitus, Type 2, Blood Glucose",

author = "M Lechleitner and S Kaser and F Hoppichler and M Roden and Raimund Weitgasser and B Ludvik and P Fasching and Y Winhofer and A Kautzky-Willer and G Schernthaner and R Prager and TC Wascher and M Clodi",

note = "Lehr-KH Krankenhaus der Barmherzigen Br{\"u}der Salzburg, Salzburg, {\"O}sterreich; Weitgasser: Universit{\"a}tsklinik f{\"u}r Innere Medizin I, LKH Salzburg - Universit{\"a}tsklinikum der Paracelsus Medizinischen Privatuniversit{\"a}t, Salzburg, {\"O}sterreich",

year = "2023",

doi = "10.1007/s00508-023-02182-8",

language = "Deutsch",

volume = "135",

pages = "98--105",

journal = "WIENER KLINISCHE WOCHENSCHRIFT",

issn = "0043-5325",

publisher = "Springer Nature",

number = "SUPPL 1",

}

TY - JOUR

T1 - Diagnostik und Therapie des Typ 1 Diabetes mellitus (Update 2023)

AU - Lechleitner, M

AU - Kaser, S

AU - Hoppichler, F

AU - Roden, M

AU - Weitgasser, Raimund

AU - Ludvik, B

AU - Fasching, P

AU - Winhofer, Y

AU - Kautzky-Willer, A

AU - Schernthaner, G

AU - Prager, R

AU - Wascher, TC

AU - Clodi, M

N1 - Lehr-KH Krankenhaus der Barmherzigen Brüder Salzburg, Salzburg, Österreich; Weitgasser: Universitätsklinik für Innere Medizin I, LKH Salzburg - Universitätsklinikum der Paracelsus Medizinischen Privatuniversität, Salzburg, Österreich

PY - 2023

Y1 - 2023

KW - BASAL-BOLUS REGIMEN

KW - GLARGINE 300 U/ML

KW - SEVERE HYPOGLYCEMIA

KW - AUTOIMMUNE-DISEASE

KW - CELIAC-DISEASE

KW - ANALOGS

KW - RISK

KW - PRONE

KW - PREVALENCE

KW - ANTIBODIES

KW - Humans

KW - Insulin/therapeutic use

KW - Diabetes Mellitus, Type 1/diagnosis

KW - Hypoglycemic Agents/therapeutic use

KW - Diabetes Mellitus, Type 2

KW - Blood Glucose

U2 - 10.1007/s00508-023-02182-8

DO - 10.1007/s00508-023-02182-8

M3 - Originalarbeit

C2 - 37101030

SN - 0043-5325

VL - 135

SP - 98

EP - 105

JO - WIENER KLINISCHE WOCHENSCHRIFT

JF - WIENER KLINISCHE WOCHENSCHRIFT

IS - SUPPL 1

ER -